Advertisement
Organisation › Details
Allogenetics GmbH
The goal of the spin-off from the Hannover Medical School (MHH) is to sustainably improve the quality of life for transplant patients by decreasing their risk of contracting deadly illnesses. Allogenetics' first-in-class therapeutic makes up a completely new approach to solving the problem of organ rejection and creates immunological invisibility of the donor organ. This disruptive innovation offers a new dimension in organ transplantation: invisible organs instead of lifelong immunosuppression. The founders are Prof. Dr. Rainer Blasczyk, head of the Institute for Transfusion Medicine and Transplant Engineering (ITT), Prof. Dr. Constanca Ferreira de Figueiredo, professor of allogeneic cell therapy at ITT, and economist Philipp Langrehr. As of September 1, Dr. Frank Schnieders took over the position of CEO. *
Start | 2022-09-07 established (s-off) | |
Predecessor | MHH, Institute of Transfusion Medicine und Transplant Engineering (ITT) | |
Industry | BIOTECH | |
Industry 2 | immunosuppresive | |
Person | Schnieders, Frank (Allogenetics 202409– CEO before Lampseq Diagnostics + Provecs Medical) | |
Person 2 | Blasczyk, Rainer (MHH 202409 Professor + Director of ITT + Co-Founder of Allogenetics) | |
Region | Hannover (Hanover) | |
Country | Germany | |
Street | 5 Feodor-Lynen-Str. | |
City | 30625 Hannover | |
Tel | +49-511-563585-110 | |
Address record changed: 2024-09-03 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Allogenetics GmbH. (9/2/24). "Press Release: The Future of Organ Transplantation Receives a Significant Boost. Allogenetics GmbH Successfully Completes Its First Funding Round, Securing €3.4 Million in Financing". | ||
Record changed: 2024-09-03 |
Advertisement
More documents for Allogenetics GmbH
- [1] Allogenetics GmbH. (9/2/24). "Press Release: The Future of Organ Transplantation Receives a Significant Boost. Allogenetics GmbH Successfully Completes Its First Funding Round, Securing €3.4 Million in Financing"....
- [2] Allogenetics GmbH. (9/2/24). "Press Release: Allogenetics GmbH sichert sich 3,4 Millionen Euro. NBank Capital führt die Finanzierungsrunde an"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top